VINEETLAB36.00

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.2 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Total Debt44.340.045.3
Net Debt44.139.728.6
Total Debt/Equity1.282.730.99
Net Debt/Equity1.272.710.63
Total Debt/EBITDA6.15-2.465.35
Net Debt/EBITDA6.12-2.443.38
Interest Coverage (EBIT/Interest)0.98-4.721.24
Total Debt/Total Capital %56.0673.2249.85
As Filed — company-reported covenants
Debt/Equity (as filed)2.731.00
Debt Service Coverage (as filed)-0.240.03
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.